CIK: 0001056807
申告総資産額
$31.4億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 2655787D | Blueprint Medicines CORP | 株式-その他 | 10.23% | — | +33.82% | |
| 2 | CCXIEUR | Chemocentryx INC | 株式-その他 | 9.22% | — | -11.83% | |
| 3 | ✓ | Cti Biopharma CORP | 株式-その他 | 9.18% | — | +337.96% | |
| 4 | CNCEEUR | Concert Pharmaceuticals INC | 株式-その他 | 7.22% | — | -1.03% | |
| 5 | ✓ | Oncothyreon INC | 株式-その他 | 7.11% | — | +14.91% | |
| 6 | ✓ | Vitae Pharmaceuticals INC | 株式-その他 | 6.36% | — | -13.24% | |
| 7 | IRWD | Ironwood Pharmaceuticals INC | 株式-その他 | 5.80% | — | -39.77% | |
| 8 | CYTK | Cytokinetics INC | 株式-ヘルスケア | 5.21% | — | +38.62% | |
| 9 | ARRYEUR | Array Biopharma INC | 株式-その他 | 4.81% | — | -30.97% | |
| 10 | FWRD | Forward Air Corporation | 株式-その他 | 4.67% | — | +41.81% | |
| 11 | ✓ | Oncomed Pharmaceuticals INC | 株式-その他 | 3.81% | — | -27.95% | |
| 12 | EXEL 4.25 08-15-19 | Exelixis INC | 株式-ヘルスケア | 3.78% | — | -30.82% | |
| 13 | ✓ | Loxo Oncology INC | 株式-その他 | 3.45% | — | -53.56% | |
| 14 | ARQLUSD | Arqule INC | 株式-その他 | 2.52% | — | +3.71% | |
| 15 | ✓ | Qlt INC | 株式-その他 | 2.43% | — | +43.53% | |
| 16 | CTMX | Cytomx Therapeutics INC | 株式-その他 | 2.17% | — | — | |
| 17 | ✓ | Tobira Therapeutics Inc | 株式-その他 | 2.15% | — | +6.65% | |
| 18 | FPRX | Five Prime Therapeutics INC | 株式-その他 | 2.12% | — | — | |
| 19 | ✓ | Nivalis Therapeutics INC | 株式-その他 | 1.58% | — | — | |
| 20 | XENE | Xenon Pharmaceuticals INC | 株式-その他 | 1.54% | — | +8.69% | |
| 21 | ✓ | Gtx INC Del | 株式-その他 | 1.33% | — | +3.63% | |
| 22 | ✓ | Sunesis Pharmaceuticals INC | 株式-その他 | 0.73% | — | +91.10% | |
| 23 | ✓ | Pain Therapeutics INC | 株式-その他 | 0.55% | — | +99.44% | |
| 24 | ✓ | Catalyst Biosciences INC | 株式-その他 | 0.52% | — | -4.89% | |
| 25 | GBIM | Globeimmune INC | 株式-その他 | 0.43% | — | -3.06% | |
| 26 | ARRY 3 06-01-20 | Array Bio INC | 株式-その他 | 0.40% | — | — | |
| 27 | ✓ | Mast Therapeutics INC | 株式-その他 | 0.26% | — | -27.57% | |
| 28 | CALAEUR | Calithera Biosciences INC | 株式-その他 | 0.22% | — | -63.22% | |
| 29 | ✓ | Biota Pharmaceutials INC | 株式-その他 | 0.12% | — | — | |
| 30 | ✓ | Nephrogenex INc | 株式-その他 | 0.11% | — | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | ✓ | Cti Biopharma CORP | +6.2% | +337.96% | 増加 |
| 2 | 2655787D | Blueprint Medicines CORP | +2.9% | +33.82% | 増加 |
| 3 | CYTK | Cytokinetics INC | +2.4% | +38.62% | 増加 |
| 4 | ✓ | Vitae Pharmaceuticals INC | +1.1% | -13.24% | 減少 |
| 5 | ✓ | Qlt INC | +0.4% | +43.53% | 増加 |
| 6 | ✓ | Sunesis Pharmaceuticals INC | +0.3% | +91.10% | 増加 |
| 7 | ✓ | Pain Therapeutics INC | +0.2% | +99.44% | 増加 |
| 8 | GBIM | Globeimmune INC | +0.1% | -3.06% | 減少 |
| 9 | ARQLUSD | Arqule INC | 0% | +3.71% | 増加 |
| 10 | ✓ | Biota Pharmaceutials INC | 0% | — | 変化なし |
| 11 | CCXIEUR | Chemocentryx INC | 0% | -11.83% | 減少 |
| 12 | ARRY 3 06-01-20 | Array Bio INC | -0.1% | — | 変化なし |
| 13 | ✓ | Tobira Therapeutics Inc | -0.1% | +6.65% | 増加 |
| 14 | FWRD | Forward Air Corporation | -0.2% | +41.81% | 増加 |
| 15 | XENE | Xenon Pharmaceuticals INC | -0.2% | +8.69% | 増加 |
| 16 | CALAEUR | Calithera Biosciences INC | -0.3% | -63.22% | 減少 |
| 17 | ✓ | Gtx INC Del | -0.3% | +3.63% | 増加 |
| 18 | ✓ | Mast Therapeutics INC | -0.3% | -27.57% | 減少 |
| 19 | ✓ | Catalyst Biosciences INC | -0.4% | -4.89% | 減少 |
| 20 | ✓ | Oncomed Pharmaceuticals INC | -0.8% | -27.95% | 減少 |
| 21 | CNCEEUR | Concert Pharmaceuticals INC | -1.3% | -1.03% | 減少 |
| 22 | ✓ | Oncothyreon INC | -2% | +14.91% | 増加 |
| 23 | ✓ | Loxo Oncology INC | -2% | -53.56% | 減少 |
| 24 | EXEL 4.25 08-15-19 | Exelixis INC | -2.9% | -30.82% | 減少 |
| 25 | ARRYEUR | Array Biopharma INC | -4.1% | -30.97% | 減少 |
| 26 | IRWD | Ironwood Pharmaceuticals INC | -4.5% | -39.77% | 減少 |
| 27 | CTMX | Cytomx Therapeutics INC | — | NEW | 新規購入 |
| 28 | FPRX | Five Prime Therapeutics INC | — | NEW | 新規購入 |
| 29 | ✓ | Nivalis Therapeutics INC | — | NEW | 新規購入 |
| 30 | ✓ | Nephrogenex INc | — | NEW | 新規購入 |
| 31 | ✓ | — | EXIT | 全売却 |